Norman David Eansor insider trades

Open-market stock purchases and sales by Norman David Eansor, Director at Marker Therapeutics, Inc, from SEC Form 4 filings since Jul 2, 2015.

Recent trades

DateStockTradeValue
Nov 17, 2025MRKR Marker Therapeutics, IncBought (not open market)—
Nov 17, 2025MRKR Marker Therapeutics, IncBought (not open market)—

Companies traded

  • MRKR Marker Therapeutics, Inc: 1 buy, last Nov 17, 2025
  • TECH BIO-TECHNE Corp: 30 sales, last Nov 16, 2021

Get free alerts when Norman David Eansor files a new trade →